
Electrocardiograph (ECG) Market Report 2026
Global Outlook – By Product (Holter Monitors, Resting Electrocardiograph (ECG), Stress Electrocardiograph (ECG), Event Recorders, Other Products), By Technology (Portable ECG Systems, Wireless ECG Systems), By Lead Type (Single Lead ECG, 2 Lead ECG, 3 Lead ECG, 6 Lead ECG, 12-Lead ECG), By End User (Hospitals And Clinics, Home Settings And Ambulatory Surgical Centers (ASCs), Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Electrocardiograph (ECG) Market Overview
• Electrocardiograph (ECG) market size has reached to $9.48 billion in 2025 • Expected to grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: The Rising Cases of Cardiovascular Diseases Fueling Growth of the Electrocardiograph (ECG) Market Due to Ageing Populations and Chronic Disease Prevalence • Market Trend: Innovative AI-Enabled Medical Devices Enhance Diagnostic Accuracy And Accessibility • North America was the largest region in 2025.What Is Covered Under Electrocardiograph (ECG) Market?
An electrocardiograph (ECG) is a medical device that is used to record the heart's electrical activity over time. It is used to record the heart's electrical activity. The heart’s electrical activity is recorded using small metal electrodes placed on the chest, arms, and legs. The main products of electrocardiographs (ECG) are holter monitors, resting electrocardiographs (ECG), stress electrocardiographs (ECG), event recorders, and others. Holter monitors are portable ECG devices that continuously record the heart's activity over 24 to 48 hours. The technologies involved are portable ECG systems, wireless ECG systems that consist of single-lead ECG, 2-lead ECG, 3-lead ECG, 6-lead ECG, and 12-lead ECG for hospitals, clinics, home settings and ambulatory surgical centers (ASCs), and others end users.
What Is The Electrocardiograph (ECG) Market Size and Share 2026?
The electrocardiograph (ecg) market size has grown strongly in recent years. It will grow from $9.48 billion in 2025 to $10.36 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of hospital diagnostic infrastructure, increasing use of non-invasive diagnostic tools, growth in cardiac screening programs, availability of compact ecg systems.What Is The Electrocardiograph (ECG) Market Growth Forecast?
The electrocardiograph (ecg) market size is expected to see strong growth in the next few years. It will grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of home-based cardiac monitoring, rising integration of ai-based ecg analysis, growing demand for continuous patient monitoring, expansion of telecardiology services, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of portable and wearable ecg devices, rising integration of wireless ecg monitoring systems, growing use of remote cardiac monitoring solutions, expansion of multi-lead diagnostic capabilities, enhanced focus on continuous heart rhythm monitoring.Global Electrocardiograph (ECG) Market Segmentation
1) By Product: Holter Monitors, Resting Electrocardiograph (ECG), Stress Electrocardiograph (ECG), Event Recorders, Other Products 2) By Technology: Portable ECG Systems, Wireless ECG Systems 3) By Lead Type: Single Lead ECG, 2 Lead ECG, 3 Lead ECG, 6 Lead ECG, 12-Lead ECG 4) By End User: Hospitals And Clinics, Home Settings And Ambulatory Surgical Centers (ASCs), Other End Users Subsegments: 1) By Holter Monitors: 24-Hour Holter Monitors, 48-Hour Holter Monitors, 7-Day Holter Monitors 2) By Resting Electrocardiograph (ECG): Single-Channel Resting ECG, Multi-Channel Resting ECG 3) By Stress Electrocardiograph (ECG): Treadmill Stress ECG, Pharmacological Stress ECG 4) By Event Recorders: Handheld Event Recorders, Implantable Loop Recorders 5) By Other Products: Mobile ECG Monitors, Telemetry ECG Systems, AccessoriesWhat Is The Driver Of The Electrocardiograph (ECG) Market?
The rising cases of cardiovascular diseases are expected to boost the electrocardiograph (ECG) market going forward. Cardiovascular disease is a group of conditions affecting the heart and blood vessels. These conditions include coronary artery disease, heart failure, arrhythmias, and heart valve problems. ECGs are essential for diagnosing, treating, and managing various cardiovascular diseases. They help doctors evaluate the heart's electrical activity and identify abnormalities that may indicate a heart condition. ECGs are an essential part of the diagnostic process for many heart-related states and will continue to need electrocardiographs for treatment, thus supporting the market growth. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising cases of cardiovascular diseases are driving the growth of the ECG market.Key Players In The Global Electrocardiograph (ECG) Market
Major companies operating in the electrocardiograph (ecg) market are Koninklijke Philips N.V., Nihon Kohden Corporation, SCHILLER AG, Fukuda Denshi Co. Ltd., Mindray Bio-Medical Electronics Co. Ltd., Medtronic Plc, General Electric Company, Siemens Healthineers, Spacelabs Healthcare, Mortara Instrument Inc., AliveCor Inc., BPL Medical Technologies, Allengers Medical Systems Limited, Compumedics Limited, Bionet Co. Ltd., Edan Instruments Inc., Norav Medical Ltd., QRS Diagnostic LLC, Biotronik SE & Co. KG, Schwarzer Cardiotek GmbH, Mega Electronics Ltd., Seers MedicalGlobal Electrocardiograph (ECG) Market Trends and Insights
Major companies operating in the elastography imaging market are focusing on developing innovative solutions, such as AI enabled liver elastography systems, to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes. An AI enabled liver elastography system is an advanced ultrasound device that uses artificial intelligence to assess liver stiffness and detect liver diseases more accurately and efficiently. For instance, in July 2025, AliveCor Inc., a US-based medical device company, launched Kardia 12L as a handheld, AI-powered 12 lead ECG system in India, positioned as the first of its kind with a single cable, pocket sized design intended for use by healthcare professionals and approved by India’s CDSCO regulator. These devices have a unique single-cable design and are capable of detecting 35 cardiac conditions, including arrhythmias and acute myocardial infarction. It is highly portable, weighing only 135 grams, battery-operated, and fits easily in a physician’s pocket, making it far more convenient than traditional ECG machines. The device requires minimal training, offers quick, non-invasive readings without the patient needing to fully disrobe, and has received regulatory approval from India’s CDSCO for clinical use, significantly enhancing cardiac diagnostics accessibility in India.What Are Latest Mergers And Acquisitions In The Electrocardiograph (ECG) Market?
In May 2024, WearLinq Inc., a US-based provider of wearable health monitoring and diagnosis solutions, acquired AMI Cardiac Monitoring for an undisclosed amount. Through this acquisition, WearLinq aims to bolster its cardiac health technology capabilities and broaden its product offerings, enabling the integration of AMI Cardiac Monitoring's innovative solutions to deliver more comprehensive monitoring tools for healthcare providers and patients. AMI Cardiac Monitoring LLC is a US-based medical technology company that provides remote heart monitoring services.Regional Outlook
North America was the largest region in the electrocardiograph (ECG) market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Electrocardiograph (ECG) Market?
The electrocardiograph market consists of revenues earned by entities by providing patient monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrocardiograph market also includes sales of diagnostic ECGs, automatic external defibrillators (AEDs), and ambulatory holter ECG recorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Electrocardiograph (ECG) Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $10.36 billion |
| Revenue Forecast In 2035 | $14.92 billion |
| Growth Rate | CAGR of 9.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Technology, Lead Type, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Koninklijke Philips N.V., Nihon Kohden Corporation, SCHILLER AG, Fukuda Denshi Co. Ltd., Mindray Bio-Medical Electronics Co. Ltd., Medtronic Plc, General Electric Company, Siemens Healthineers, Spacelabs Healthcare, Mortara Instrument Inc., AliveCor Inc., BPL Medical Technologies, Allengers Medical Systems Limited, Compumedics Limited, Bionet Co. Ltd., Edan Instruments Inc., Norav Medical Ltd., QRS Diagnostic LLC, Biotronik SE & Co. KG, Schwarzer Cardiotek GmbH, Mega Electronics Ltd., Seers Medical |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
